Global Technology – August 2019

For more than three decades, a gene called MYC has become one of the hottest targets for cancer researchers around the world.  MYC is known to drive tumor growth in nearly all cancer types.  Unfortunately, successfully targeting the MYC gene has, until recently, been an insurmountable challenge.

But now, researchers at Purdue University have discovered a novel set of MYC promoter G-quadruplex stabilizers that have demonstrated anticancer activity in human cancer cell cultures. 

The new anticancer agents may control tumor growth .....

This content is for BUSINESS BRIEFINGS members only.

Leave a Reply

Your email address will not be published. Required fields are marked *